Nischarin has also been demonstrated to be significantly downregulated in human breast cancer tissues compared with normal tissues in patients with breast cancer from the USA, and the overexpression of Nischarin in MDA-MB-231 breast cancer cells significantly inhibited metastasis, suggesting that Nischarin may function as a tumor suppressor (27). This evidence concerns the gene NISCH and breast cancer.